Search by Drug Name or NDC
NDC 76045-0004-11 Morphine Sulfate 2 mg/mL Details
Morphine Sulfate 2 mg/mL
Morphine Sulfate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi, USA LLC. The primary component is MORPHINE SULFATE.
MedlinePlus Drug Summary
Morphine injection is used to relieve moderate to severe pain. Morphine is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 76045-0004-11Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Morphine Injection
Product Information
| NDC | 76045-0004 |
|---|---|
| Product ID | 76045-004_37b9ad12-9117-471a-9362-e0a5e7031a1e |
| Associated GPIs | 65100055102005 |
| GCN Sequence Number | 004070 |
| GCN Sequence Number Description | morphine sulfate SYRINGE 2 MG/ML INJECTION |
| HIC3 | H3A |
| HIC3 Description | OPIOID ANALGESICS |
| GCN | 16032 |
| HICL Sequence Number | 001694 |
| HICL Sequence Number Description | MORPHINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Morphine Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Morphine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | MORPHINE SULFATE |
| Labeler Name | Fresenius Kabi, USA LLC |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA204223 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 76045-0004-11 (76045000411)
| NDC Package Code | 76045-004-11 |
|---|---|
| Billing NDC | 76045000411 |
| Package | 10 SYRINGE, GLASS in 1 CARTON (76045-004-11) / 1 mL in 1 SYRINGE, GLASS (76045-004-01) |
| Marketing Start Date | 2019-11-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |